BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 25422915)

  • 21. MicroRNAs target the Wnt/β‑catenin signaling pathway to regulate epithelial‑mesenchymal transition in cancer (Review).
    Lei Y; Chen L; Zhang G; Shan A; Ye C; Liang B; Sun J; Liao X; Zhu C; Chen Y; Wang J; Zhang E; Deng L
    Oncol Rep; 2020 Oct; 44(4):1299-1313. PubMed ID: 32700744
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extracellular vesicle-mediated crosstalk between NPCE cells and TM cells result in modulation of Wnt signalling pathway and ECM remodelling.
    Lerner N; Schreiber-Avissar S; Beit-Yannai E
    J Cell Mol Med; 2020 Apr; 24(8):4646-4658. PubMed ID: 32168427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long non‑coding RNA CASC2 suppresses pancreatic cancer cell growth and progression by regulating the miR‑24/MUC6 axis.
    Xu DF; Wang LS; Zhou JH
    Int J Oncol; 2020 Feb; 56(2):494-507. PubMed ID: 31894271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.
    Rawat M; Kadian K; Gupta Y; Kumar A; Chain PSG; Kovbasnjuk O; Kumar S; Parasher G
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31557962
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UTX/KDM6A Deletion Promotes Recovery of Spinal Cord Injury by Epigenetically Regulating Vascular Regeneration.
    Ni S; Luo Z; Jiang L; Guo Z; Li P; Xu X; Cao Y; Duan C; Wu T; Li C; Lu H; Hu J
    Mol Ther; 2019 Dec; 27(12):2134-2146. PubMed ID: 31495776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-23a promotes pancreatic cancer metastasis by targeting epithelial splicing regulator protein 1.
    Wu G; Li Z; Jiang P; Zhang X; Xu Y; Chen K; Li X
    Oncotarget; 2017 Oct; 8(47):82854-82871. PubMed ID: 29137308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth.
    Michael JV; Wurtzel JGT; Mao GF; Rao AK; Kolpakov MA; Sabri A; Hoffman NE; Rajan S; Tomar D; Madesh M; Nieman MT; Yu J; Edelstein LC; Rowley JW; Weyrich AS; Goldfinger LE
    Blood; 2017 Aug; 130(5):567-580. PubMed ID: 28500171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology.
    Ehrlich L; Hall C; Meng F; Lairmore T; Alpini G; Glaser S
    Gene Expr; 2017 Jul; 17(3):251-263. PubMed ID: 28485270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The crosstalk between microRNAs and the Wnt/β-catenin signaling pathway in cancer.
    Peng Y; Zhang X; Feng X; Fan X; Jin Z
    Oncotarget; 2017 Feb; 8(8):14089-14106. PubMed ID: 27793042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma.
    Janky R; Binda MM; Allemeersch J; Van den Broeck A; Govaere O; Swinnen JV; Roskams T; Aerts S; Topal B
    BMC Cancer; 2016 Aug; 16():632. PubMed ID: 27520560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study design and data analysis considerations for the discovery of prognostic molecular biomarkers: a case study of progression free survival in advanced serous ovarian cancer.
    Qin LX; Levine DA
    BMC Med Genomics; 2016 Jun; 9(1):27. PubMed ID: 27282150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA in pancreatic cancer.
    Yonemori K; Kurahara H; Maemura K; Natsugoe S
    J Hum Genet; 2017 Jan; 62(1):33-40. PubMed ID: 27251005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The miR-24-Bim pathway promotes tumor growth and angiogenesis in pancreatic carcinoma.
    Liu R; Zhang H; Wang X; Zhou L; Li H; Deng T; Qu Y; Duan J; Bai M; Ge S; Ning T; Zhang L; Huang D; Ba Y
    Oncotarget; 2015 Dec; 6(41):43831-42. PubMed ID: 26517093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oncogenic miR-23a in Pancreatic Ductal Adenocarcinogenesis Via Inhibiting APAF1.
    Liu N; Sun YY; Zhang XW; Chen S; Wang Y; Zhang ZX; Song SW; Qiu GB; Fu WN
    Dig Dis Sci; 2015 Jul; 60(7):2000-8. PubMed ID: 25701323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-23a/-24-induced gene silencing results in mesothelial cell integration of pancreatic cancer.
    Listing H; Mardin WA; Wohlfromm S; Mees ST; Haier J
    Br J Cancer; 2015 Jan; 112(1):131-9. PubMed ID: 25422915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
    Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
    Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel feedback loop between high MALAT-1 and low miR-200c-3p promotes cell migration and invasion in pancreatic ductal adenocarcinoma and is predictive of poor prognosis.
    Zhuo M; Yuan C; Han T; Cui J; Jiao F; Wang L
    BMC Cancer; 2018 Oct; 18(1):1032. PubMed ID: 30352575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells.
    Kent OA; Mullendore M; Wentzel EA; López-Romero P; Tan AC; Alvarez H; West K; Ochs MF; Hidalgo M; Arking DE; Maitra A; Mendell JT
    Cancer Biol Ther; 2009 Nov; 8(21):2013-24. PubMed ID: 20037478
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.